Synthesized peptide derived from internal of human PPP2R1B.
Conjugate
Unconjugated
Applications
Application Notes
WB: 1:500-1:3000 IHC: 1:50-1:100
General Notes
This product (Catalog No. DPABH-28938) is a rabbit-derived IgG polyclonal antibody raised against human PPP2R1B. It has been affinity purified by protein A. This gene encodes a constant regulatory subunit of protein phosphatase 2. Protein phosphatase 2 is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. The constant regulatory subunit A serves as a scaffolding molecule to coordinate the assembly of the catalytic subunit and a variable regulatory B subunit. This gene encodes a beta isoform of the constant regulatory subunit A. Mutations in this gene have been associated with some lung and colon cancers. Alternatively spliced transcript variants have been described. DPABH-28938 is suitable for use in Western blot (WB) (1:500–1:3,000), IHC (1:50–1:100) applications. DPABH-28938 is supplied as a liquid formulation in PBS (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
Target
Alternative Names
2AAB; beta isoform of regulatory subunit A; protein phosphatase 2; PP2A; A
My Review for Rabbit Anti-Human PPP2R1B (internal) Polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.